Skip to Main content Skip to Navigation
Journal articles

[Synchroton radiotherapy].

Abstract : Radiation therapy is commonly used in the treatment of cancer. The normal tissue tolerance can be a limit to deliver enough dose to the tumor to be curative. The synchrotron beam presents some interesting physical properties, which could decrease this limitation. Synchrotron beam is a medium energy X-ray nearly parallel beam with high intensity. Three methods are under preclinical investigations: the microbeam, the minibeam and the stereotactic radiotherapy. The first two use a geometric irradiation effect called spatial fractioning. The last one use highly conformational irradiation geometry combined with a dose enhancement due to the presence of high-Z element in the target. Synchrotron radiotherapy preclinical experiments have shown some curative effect on rodent glioma models. Following these encouraging results a phase I/II clinical trial of iodinated enhanced stereotactic synchrotron radiotherapy is currently being prepared at the European Synchrotron Radiation Facility.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00522394
Contributor : Raphael Serduc <>
Submitted on : Friday, September 9, 2011 - 10:40:56 AM
Last modification on : Friday, June 1, 2018 - 2:02:05 PM
Long-term archiving on: : Saturday, December 3, 2016 - 12:59:35 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

U836 | UGA

Citation

Pierre Deman, M. Edouard, Sébastien Besse, Mathias Vautrin, Hélène Elleaume, et al.. [Synchroton radiotherapy].. La Revue De Médecine Interne, Elsevier, 2010, 31 (8), pp.586-9. ⟨10.1016/j.revmed.2009.12.012⟩. ⟨inserm-00522394⟩

Share

Metrics

Record views

209